ライフサイエンスコーパス: nasopharyngeal

1 Nasopharyngeal acquisition and prevalence of ANSP during

2 dels suggest that influenza infection favors nasopharyngeal acquisition of pneumococci.

3 and dry air in the physiological response to nasopharyngeal acquisition of the pneumococcus.

4 atistically significant interactions between nasopharyngeal airway CCL5 levels and microbiota profile

5 Nasopharyngeal airway metabolome profiles significantly

6 To determine the relations among the nasopharyngeal airway metabolome profiles, microbiome pr

7 genome shotgun sequencing) approaches to 144 nasopharyngeal airway samples collected within 24 hours

8 ts; (2) obese OSAS adolescents had a smaller nasopharyngeal airway than control subjects; (3) the siz

9 Pneumococcal interactions with human nasopharyngeal and bronchial fibroblasts and epithelial

10 zed nasopharyngeal pneumococcal carriage and nasopharyngeal and oropharyngeal NTHi carriage in 13 541

11 Nasopharyngeal and oropharyngeal swab specimens were tes

12 tandardized clinical evaluation and provided nasopharyngeal and oropharyngeal swabs and induced sputu

13 Nasopharyngeal and oropharyngeal swabs were collected du

14 influenza-like illness were interviewed, and nasopharyngeal and oropharyngeal swabs were collected to

15 Juvenile nasopharyngeal angiofibroma (JNA) showed distinctly high

16 Xpert combined on nasopharyngeal aspirate and stool had intention-to-diagn

17 The combination of nasopharyngeal aspirate and stool sample is a promising

18 hildren aged >/=10 years (standard samples); nasopharyngeal aspirate and stool were taken for all chi

19 After confirming rhinovirus from nasopharyngeal aspirate by using PCR, 79 children with a

20 rus that was first identified in 2004 in the nasopharyngeal aspirate from a 7-month-old patient with

21 Nasopharyngeal aspirate samples were analyzed with polym

22 eolar lavage fluid, 5 plasma, 2 serum, and 1 nasopharyngeal aspirate) were originally found to be pos

23 This study looked at 128 nasopharyngeal aspirates (NPA) and 162 throat swabs (TS)

24 n whom real-time PCR for RV was performed in nasopharyngeal aspirates (NPAs) and bronchoalveolar lava

25 such as flocked nasopharyngeal swabs (NPSs), nasopharyngeal aspirates (NPAs), and induced sputum, hav

26 Site teams collected clinical data, nasopharyngeal aspirates and serum.

27 ing was performed for respiratory viruses in nasopharyngeal aspirates collected from children aged <5

28 real-time polymerase chain reaction to test nasopharyngeal aspirates for 16 viruses.

29 Nasopharyngeal aspirates were collected from 363 infants

30 Nasopharyngeal aspirates were tested for influenza virus

31 were achieved for primary clinical samples (nasopharyngeal aspirates) from the same individuals.

32 Flocked nasopharyngeal swabs, nasopharyngeal aspirates, and induced sputum performed s

33 s hospitalized for bronchiolitis and collect nasopharyngeal aspirates.

34 ssay and to determine limits of detection in nasopharyngeal aspirates.

35 Infants were sampled by nasosorption and nasopharyngeal aspiration (NPA).

36 of CCR5(+)/CCR6(+)/CD11b(+)/CD11c(+) DCs in nasopharyngeal-associated lymphoid tissue (NALT) and cer

37 to elucidate the dynamics of transmission of nasopharyngeal bacteria.

38 espiratory infection, even in the absence of nasopharyngeal bacterial colonization.

39 serotypes may mitigate the impact of PCV7 on nasopharyngeal bacterial community structure and ecology

40 The nasopharyngeal bacterial load was assessed in naive anim

41 capacity for NTHi phagocytosis and increased nasopharyngeal bacterial loads in ccl3(-/-) mice.

42 technique for treatment of locally recurrent nasopharyngeal cancer (lrNPC).

43 Respiratory tract cancers, including both nasopharyngeal cancer and lung cancer, are strongly asso

44 15 men with upper airway cancer (including 1 nasopharyngeal cancer), 92 men with leukemia, and 45 men

45 isease as well as EBV-positive lymphomas and nasopharyngeal cancer, although a recent study also show

46 Childhood nasopharyngeal cancers are often diagnosed at an advance

47 U, expression is frequently downregulated in nasopharyngeal carcinoma (NPC) and many other tumors due

48 urrently involved in structural variation in nasopharyngeal carcinoma (NPC) and the identification of

49 Nasopharyngeal carcinoma (NPC) cell lines are important

50 ypes, including Burkitt lymphoma (BL) cells, nasopharyngeal carcinoma (NPC) cells, and lymphoblastoid

51 Undifferentiated nasopharyngeal carcinoma (NPC) has a 100% association wi

52 Nasopharyngeal carcinoma (NPC) has extremely skewed ethn

53 The epithelial-derived nasopharyngeal carcinoma (NPC) is a rare tumor in most o

54 Nasopharyngeal carcinoma (NPC) is a unique epithelial ma

55 Nasopharyngeal carcinoma (NPC) is an aggressive head and

56 Nasopharyngeal carcinoma (NPC) is an EBV-associated epit

57 Nasopharyngeal carcinoma (NPC) is an Epstein-Barr virus

58 Nasopharyngeal carcinoma (NPC) is an Epstein-Barr virus-

59 Nasopharyngeal carcinoma (NPC) is an invasive cancer wit

60 Radioresistance of EBV-associated nasopharyngeal carcinoma (NPC) is associated with poor p

61 Nasopharyngeal carcinoma (NPC) is closely associated wit

62 reatment of EBV-associated cancer.IMPORTANCE Nasopharyngeal carcinoma (NPC) is highly associated with

63 l OPC regional lymph node (N) categories and nasopharyngeal carcinoma (NPC) N categories.

64 Given salvage treatment for recurrent nasopharyngeal carcinoma (NPC) remains a clinical dilemm

65 de polymorphisms (SNPs) in PIN1 promoter and nasopharyngeal carcinoma (NPC) risk with a small sample

66 frequently present in Chinese and Indonesian nasopharyngeal carcinoma (NPC) samples.

67 's lymphoma, diffuse large B-cell lymphomas, nasopharyngeal carcinoma (NPC), and lymphomas that devel

68 g tumors that have latent infection, such as nasopharyngeal carcinoma (NPC), and oral hairy leukoplak

69 survival rates in cancer patients, including nasopharyngeal carcinoma (NPC), breast cancer and hepato

70 cellular differentiation is a key feature of nasopharyngeal carcinoma (NPC), but it also presents as

71 ly linked with human B-cell malignancies and nasopharyngeal carcinoma (NPC), establishes three types

72 associated with many human cancers, such as nasopharyngeal carcinoma (NPC), Hodgkin's disease, and g

73 n-Barr virus (EBV), aetiologically linked to nasopharyngeal carcinoma (NPC), is the first human virus

74 velopment of CD44(+/High) stem-like cells in nasopharyngeal carcinoma (NPC).

75 in-Barr virus (EBV) to the aggressiveness of nasopharyngeal carcinoma (NPC).

76 ethylation are hallmarks of undifferentiated nasopharyngeal carcinoma (NPC).

77 an oncogene in epithelial carcinomas such as nasopharyngeal carcinoma (NPC).

78 ssion of the highly invasive EBV malignancy, nasopharyngeal carcinoma (NPC).

79 target to improve the therapeutic regimen of nasopharyngeal carcinoma (NPC).

80 Radiotherapy is the standard therapy for nasopharyngeal carcinoma (NPC); however, radioresistance

81 ially has classified formaldehyde as causing nasopharyngeal carcinoma and myeloid leukemia.

82 chemotherapy in patients with non-metastatic nasopharyngeal carcinoma and obtained updated data for p

83 This resembles the N classification of nasopharyngeal carcinoma but without a lower neck lymph

84 llular accumulation of HIF-1alpha of hypoxic nasopharyngeal carcinoma cells and mediates the radiatio

85 s type I interferon production, and in human nasopharyngeal carcinoma cells results in almost complet

86 s the radiation-resistant phenotype of these nasopharyngeal carcinoma cells.

87 ts, and arrested cells at the G0/G1 phase in nasopharyngeal carcinoma CNE-2Z cells.

88 We further demonstrate in nasopharyngeal carcinoma CNE2 and 5-8F cells that this c

89 ts in the hypoxic regions of tumor formed by nasopharyngeal carcinoma CNE2 cells and breast cancer MD

90 Nasopharyngeal carcinoma is a major cancer that develops

91 Nasopharyngeal carcinoma is a rarely seen tumor in child

92 MATERIAL/METHODS: The study included 10 nasopharyngeal carcinoma patients under the age of 18 ye

93 ry leukoplakia) or latent infection (such as nasopharyngeal carcinoma).

94 onsistently been associated with the risk of nasopharyngeal carcinoma, and patients with Hodgkin lymp

95 a herpesvirus linked to malignancies such as nasopharyngeal carcinoma, Burkitt's lymphoma, and Hodgki

96 he development of various cancers, including nasopharyngeal carcinoma, gastric cancer, Burkitt lympho

97 for an increased hazard of myeloid leukemia, nasopharyngeal carcinoma, or other upper airway tumors f

98 val in patients with locoregionally advanced nasopharyngeal carcinoma.

99 as an aetiological factor in B lymphomas and nasopharyngeal carcinoma.

100 oth lymphoid and epithelial cells, including nasopharyngeal carcinoma.

101 e development of multiple cancers, including nasopharyngeal carcinoma.

102 showed that it improves overall survival in nasopharyngeal carcinoma.

103 as Burkitt and Hodgkin lymphoma, as well as nasopharyngeal carcinoma.

104 also causes nonlymphoid malignancies such as nasopharyngeal carcinoma.

105 epistaxis for 2 years and was diagnosed with nasopharyngeal carcinoma.

106 cies Hodgkin and Burkitt lymphoma as well as nasopharyngeal carcinoma.

107 to explore infectious agents associated with nasopharyngeal carcinomas (NPCs), we employed our high-t

108 produced complete remissions of EBV-positive nasopharyngeal carcinomas and lymphomas developing in im

109 actionated radiotherapy, or including mostly nasopharyngeal carcinomas were excluded.

110 ithelial cells derived from gastric cancers, nasopharyngeal carcinomas, and normal oral keratinocytes

111 ect against disease indirectly by disrupting nasopharyngeal carriage (e.g., herd protection).

112 ji examined the immunogenicity and effect on nasopharyngeal carriage after 0, 1, 2, or 3 doses of 7-v

113 A murine model of nasopharyngeal carriage and an experimental human pneumo

114 f pneumococcus contributes to its success in nasopharyngeal carriage by modulating resistance to phag

115 We determined the prevalence of nasopharyngeal carriage by undertaking cross-sectional s

116 ells in the establishment and maintenance of nasopharyngeal carriage in mice and humans.

117 The prevalence of nasopharyngeal carriage is low and the profile of Hib an

118 ram-negative bacterium with an oropharyngeal/nasopharyngeal carriage niche that is associated with a

119 Over 90 different serotypes exist, and nasopharyngeal carriage of multiple serotypes is common.

120 Nasopharyngeal carriage of PCV7 and 23vPPV serotypes was

121 Nasopharyngeal carriage of PCV7 serotypes in Group 1 was

122 Nasopharyngeal carriage of Streptococcus pneumoniae is a

123 nvaccinated individuals, mediated by reduced nasopharyngeal carriage of vaccine-serotype pneumococci.

124 Nasopharyngeal carriage prevalence of pneumococcus was m

125 We evaluated whether data from nasopharyngeal carriage studies can be used to accuratel

126 ease course evolves from one of asymptomatic nasopharyngeal carriage to overt disease.

127 gression of stable asymptomatic pneumococcal nasopharyngeal carriage to pneumonia and invasive diseas

128 effectiveness, the impact of the vaccine on nasopharyngeal carriage, and population immunity after i

129 sted for vaccine efficacy in mouse models of nasopharyngeal carriage, otitis media, pneumonia, sepsis

130 e patterns, altering density of pneumococcal nasopharyngeal carriage, reducing phagocytic killing, an

131 human pathogen associated with asymptomatic nasopharyngeal carriage.

132 arried at higher densities than ST618 during nasopharyngeal carriage.

133 chanisms underlying noninvasive pneumococcal nasopharyngeal carriage.

134 ngitidis can be transmitted via asymptomatic nasopharyngeal carriage.

135 persons, with higher rates among those with nasopharyngeal carriage.

136 associated with asymptomatic carriage in the nasopharyngeal cavity, as opposed to the disease state.

137 n takes place in fibroblast, epithelial, and nasopharyngeal cell lines that express LMP1 stably and t

138 eumococci to drive TGF-beta1 production from nasopharyngeal cells in vivo and show that an immune tol

139 killing, biofilm production, and adhesion to nasopharyngeal cells, though serotype 33F survived short

140 biofilm formation, and increased adhesion to nasopharyngeal cells.

141 In a mouse nasopharyngeal colonisation model, black carbon caused S

142 type-matched invasive strain increased mouse nasopharyngeal colonization and adherence to cultured hu

143 ile baboons with BPZE1 resulted in transient nasopharyngeal colonization and induction of immunoglobu

144 T -10 and -35 boxes are required for optimal nasopharyngeal colonization and virulence.

145 m the failure of current vaccines to prevent nasopharyngeal colonization by Bordetella pertussis, the

146 infection is associated with an increase in nasopharyngeal colonization density.

147 and determined the impact of the exchange on nasopharyngeal colonization in mice.

148 Nasopharyngeal colonization occurs in biofilms and prece

149 Specifically, nasopharyngeal colonization of human infants with NTHi w

150 his cohort of pre-school asthmatic children, nasopharyngeal colonization with Gram-negative bacteria

151 s in rates of recurrence, adverse events, or nasopharyngeal colonization with penicillin-nonsusceptib

152 ls were also inversely associated with early nasopharyngeal colonization with Streptococcus species a

153 s and symptomatic response), recurrence, and nasopharyngeal colonization, and we analyzed episode out

154 stent selection for high Hia expression upon nasopharyngeal colonization, confirming the key role of

155 Using a murine model of pneumococcal nasopharyngeal colonization, we show that mice deficient

156 population-level reduction of meningococcal nasopharyngeal colonization.

157 or pneumococcal resistance to stress and for nasopharyngeal colonization.

158 elop a safe experimental human model of NTHi nasopharyngeal colonization.

159 Streptococcus pneumoniae is a nasopharyngeal commensal that occasionally invades norma

160 k oxygen, high flow nasal cannula oxygen, or nasopharyngeal continuous PEEP in the presence of respir

161 agnosed with CAAP with positive pneumococcal nasopharyngeal cultures from whom viral diagnostic tests

162 A combination of HBoV1 serology and nasopharyngeal DNA quantitative PCR and mRNA RT-PCR shou

163 The mechanisms of cell-free EBV infection of nasopharyngeal epithelial cells remain elusive.

164 EBV enters nasopharyngeal epithelial cells through NRP1-facilitated

165 which subsequently promotes EBV infection in nasopharyngeal epithelial cells.

166 a commensal of humans that can colonize the nasopharyngeal epithelium for weeks to months and occasi

167 multiple carcinomas and lymphomas, including nasopharyngeal, esophageal, gastric, colorectal, renal,

168 top-performing methods were used to test 260 nasopharyngeal (field) samples collected from children i

169 tococcus pneumoniae forms part of the normal nasopharyngeal flora but can also cause a broad spectrum

170 ads, with <5% of reads derived from human or nasopharyngeal flora for 88% and 91% of samples, respect

171 HMPV - S. pneumoniae can become part of the nasopharyngeal flora, contributing to the severity of re

172 pneumococcal strains, which has changed the nasopharyngeal flora, opening the niche for entry of oth

173 HED patients arises as a result of nasal and nasopharyngeal gland deficits, reduced mucociliary clear

174 Nasopharyngeal H influenzae type b carriage was detected

175 body-mediated depletion of T cells prevented nasopharyngeal infection by S. pyogenes, but not by Stre

176 nipulate Vbeta-specific T cells to establish nasopharyngeal infection.

177 onfunctional SpeA mutant, protects mice from nasopharyngeal infection; however, only passive immuniza

178 ccal blood isolates from hospitalized UC and nasopharyngeal isolates were characterized by serotyping

179 model were recapitulated in studies of human nasopharyngeal lavages obtained during the 2009-2011 inf

180 hial lymph node, retropharyngeal lymph node, nasopharyngeal lymph node and pharyngeal tonsil collecte

181 ral infections are associated with different nasopharyngeal microbial profiles.

182 Respiratory viruses alter the nasopharyngeal microbiome and may be associated with a d

183 carriage and the bacterial component of the nasopharyngeal microbiome during infancy.

184 To test this hypothesis, we compared the nasopharyngeal microbiome of 135 previously healthy infa

185 The nasopharyngeal microbiome was assessed by sequencing the

186 We identified five nasopharyngeal microbiota clusters characterized by enri

187 f age associations between breastfeeding and nasopharyngeal microbiota composition had disappeared.

188 sis onward, we observed distinct patterns of nasopharyngeal microbiota development in infants with CF

189 cohort of 112 infants, we characterized the nasopharyngeal microbiota longitudinally from birth on (

190 ta suggest that interactions between RSV and nasopharyngeal microbiota might modulate the host immune

191 We characterized the nasopharyngeal microbiota profiles of young children wit

192 ilability and to protect themselves from the nasopharyngeal microflora and host immune response.

193 nt finding of asymptomatic ocular, oral, and nasopharyngeal MMP is clinically significant and implies

194 relative abundance of CD8(+) T cells in the nasopharyngeal mucosa in association with clearance of F

195 demonstrated that clearance of FMDV from the nasopharyngeal mucosa was associated with upregulation o

196 and bacterial commensals encountered at the nasopharyngeal mucosa.

197 d contributes to mucosal host defense of the nasopharyngeal niche, a reservoir for ME and upper respi

198 colonization, resulting in a more permissive nasopharyngeal niche.

199 ng adherence to lung HECs in vitro and mouse nasopharyngeal (NP) colonization in vivo.

200 We validated nasopharyngeal (NP) flocked specimens in universal trans

201 To determine the predictive value of nasopharyngeal (NP) sample testing for respiratory virus

202 Monthly nasopharyngeal (NP) samples were obtained to assess pneu

203 In this report, we analyzed 749 nasopharyngeal (NP) specimens collected in 2015 and 2016

204 Nasopharyngeal (NP) swab specimens from patients in a re

205 nvestigated host gene expression profiles in nasopharyngeal (NP) swabs and whole blood samples during

206 tive lytA real-time PCR (rtPCR) results from nasopharyngeal (NP) swabs distinguish community-acquired

207 At each visit, nasopharyngeal (NP) swabs were obtained from both, and s

208 PHiD-CV had no differential effect on nasopharyngeal NTHi colonization or H. influenzae densit

209 (one), pinealoblastoma (one), tongue (two), nasopharyngeal (one), thyroid (one) and testicular cance

210 We performed nasopharyngeal or nasal swabbing and/or serum sampling (

211 New diagnostic platforms often use nasopharyngeal or oropharyngeal (NP/OP) swabs for pathog

212 total of 969 of 4025 systematically selected nasopharyngeal-oropharyngeal specimens (24%) were tested

213 rganism detection by multiplex PCR in IS and nasopharyngeal/oropharyngeal (NP/OP) specimens.

214 Nasopharyngeal/oropharyngeal (NP/OP) swabs from 70 child

215 -59 months investigating pathogens in blood, nasopharyngeal/oropharyngeal (NP/OP) swabs, and induced

216 cases, and with high (>6.9 log10 copies/mL) nasopharyngeal/oropharyngeal load and C-reactive protein

217 reaction [PCR]) compared to "RSV pneumonia" (nasopharyngeal/oropharyngeal or induced sputum PCR-posit

218 Nasopharyngeal/oropharyngeal specimens were tested for H

219 tative polymerase chain reaction analysis of nasopharyngeal/oropharyngeal specimens.

220 In the 9 developing country sites, nasopharyngeal/oropharyngeal swabs from children with an

221 In 7 low- and middle-income countries, nasopharyngeal/oropharyngeal swabs from children with se

222 incidence will rely mainly on prevention of nasopharyngeal otopathogen colonization, as well as redu

223 We analyzed nasopharyngeal pneumococcal carriage and nasopharyngeal

224 least 8 at ages 18 weeks and 10 months; and nasopharyngeal pneumococcal serotype-specific carriage r

225 at infants exposed to HIV become carriers of nasopharyngeal pneumococcus earlier and more frequently

226 immunity, exert selection on members of the nasopharyngeal population, and the dynamics of selection

227 A nasopharyngeal rayon swab specimen was collected from ea

228 hat are not shared with other unencapsulated nasopharyngeal S. pneumoniae.

229 rmed by the central laboratory on a baseline nasopharyngeal sample, and had received at least one dos

230 Nasopharyngeal samples for viral load quantitation, typi

231 Deep sequencing of nasopharyngeal samples produced partial sequences for 4

232 Nasopharyngeal samples were collected from 5235 adult pi

233 laboratory-developed TaqMan PCR methods, 445 nasopharyngeal samples were tested.

234 is of childhood tuberculosis with sputum and nasopharyngeal samples.

235 ystem (Copan Diagnostics) was evaluated as a nasopharyngeal specimen collection device to be used for

236 16 S rRNA gene sequencing were performed on nasopharyngeal specimens collected at regular intervals

237 to detect 13 common respiratory viruses from nasopharyngeal specimens collected during 2028 visits fr

238 Nasopharyngeal specimens from eight (73%) of 11 children

239 On 23 blinded nasopharyngeal specimens that were pneumococcus culture

240 fication of RNA directly from human clinical nasopharyngeal specimens through a poly(ether sulfone) p

241 Eight nasopharyngeal specimens were collected by swabbing betw

242 ntitative pneumococcal (lytA) detection, and nasopharyngeal specimens were collected for detection of

243 Blood and nasopharyngeal specimens were collected to perform rapid

244 h sera and sputum were rRT-PCR positive when nasopharyngeal specimens were negative.

245 l resolution and change in viral shedding in nasopharyngeal specimens were the primary and key second

246 spective (n = 200) and prospective (n = 150) nasopharyngeal specimens, we evaluated the Nanosphere Ve

247 ha2,6-linked sialic acids predominate on the nasopharyngeal surface.

248 verse-transcription (RT) PCR were applied to nasopharyngeal swab (NPS) samples from all acutely HBoV1

249 participants with virus detectable by PCR in nasopharyngeal swab at day 3, and was assessed in partic

250 A nasopharyngeal swab FARP (NP FARP) is performed for many

251 Finally, infectious reference viruses and nasopharyngeal swab patient specimens were successfully

252 Nasopharyngeal swab samples were collected every 3-4 day

253 ticipants in 44 households a total of 15 396 nasopharyngeal swab samples were samples were collected,

254 rom each community was monitored by means of nasopharyngeal swab sampling before mass azithromycin di

255 icantly higher MERS-CoV loads, compared with nasopharyngeal swab specimens (P = .005) and sputum spec

256 ad significantly higher genome fraction than nasopharyngeal swab specimens (P = .0095 and P = .0002,

257 systematic random sampling to identify 3,000 nasopharyngeal swab specimens collected from January 200

258 During the outbreak, we collected nasopharyngeal swab specimens from patients in the Lower

259 hed by blind testing of 328 nasal/throat and nasopharyngeal swab specimens from the United Kingdom an

260 Of the 2,479 eligible nasopharyngeal swab specimens included in the prospectiv

261 Nasopharyngeal swab specimens were obtained from infants

262 Nasopharyngeal swab specimens were requested weekly, dur

263 ed, of which 13 were sputum samples, 64 were nasopharyngeal swab specimens, 30 were tracheal aspirate

264 Cerebrospinal fluid, serum samples, nasopharyngeal swab specimens, and stool specimens were

265 reverse transcriptase PCR (RT-PCR) using 411 nasopharyngeal swab specimens.

266 l targets in LRTS was comparable to that for nasopharyngeal swab specimens.

267 d high MERS-CoV antibody titers, whereas his nasopharyngeal swab was rRT-PCR negative.

268 Respiratory (nasopharyngeal swab) and blood specimens were collected

269 re i Influenza A&B was screened using frozen nasopharyngeal-swab specimens collected in viral transpo

270 erent respiratory specimens, such as flocked nasopharyngeal swabs (NPSs), nasopharyngeal aspirates (N

271 A total of 18 207 nasopharyngeal swabs (rural = 16 098; urban = 2109) were

272 Nasopharyngeal swabs and blood samples were taken among

273 al-time polymerase chain reaction (PCR) from nasopharyngeal swabs and lower tracheal specimens via in

274 We obtained nasopharyngeal swabs for pneumococcal identification and

275 Nasopharyngeal swabs from enrollees were analyzed for th

276 Each day since 2009, nasopharyngeal swabs have been obtained from the first 4

277 rmed by means of RT-PCR assay and culture of nasopharyngeal swabs obtained from participants with sym

278 ive (n= 42) and unselected (n= 67) pediatric nasopharyngeal swabs using an RNA sequencing (RNA-seq)-b

279 Nasopharyngeal swabs were collected >- 30 days after ser

280 Nasopharyngeal swabs were collected every 4-6 weeks in t

281 Nasopharyngeal swabs were taken before PCV13 immunizatio

282 Nasopharyngeal swabs were taken during respiratory episo

283 Nasopharyngeal swabs were used to assess pneumococcal co

284 Flocked nasopharyngeal swabs, nasopharyngeal aspirates, and indu

285 in buffer and 10 +/- 2 fM in 10-fold diluted nasopharyngeal swabs, which is comparable to currently a

286 gens by polymerase chain reaction of flocked nasopharyngeal swabs.

287 the Xpert Flu assay (n = 147) using archived nasopharyngeal swabs.

288 ed from bronchial specimens and 5 (19%) from nasopharyngeal swabs.

289 characterized by elevated TGF-beta1 and high nasopharyngeal T regulatory cell numbers, is crucial for

290 ice in her upper airways, a first-documented nasopharyngeal temperature of 13.8 degrees C, and a seru

291 A fine-needle aspirate of nasopharyngeal tissue demonstrated fibroadipose tissue.

292 pneumococcal disease is caused by increased nasopharyngeal transmission of the bacteria or increased

293 tions might be primarily driven by increased nasopharyngeal transmission of the bacteria.

294 the molecular aberrations that likely drive nasopharyngeal tumor development and progression.

295 yphoid fever was found in 13.3% of children, nasopharyngeal viral infection (without respiratory symp

296 Total postchallenge nasopharyngeal virulent bacterial burden of vaccinated a

297 e of subjects reported allergy, 59% had >/=1 nasopharyngeal viruses, and 24% had >/=1 intratonsillar

298 Nasopharyngeal wash specimens from case patients and con

299 was followed by quantifying colonization in nasopharyngeal washes and monitoring leukocytosis and sy

300 d specimen collection criteria, we collected nasopharyngeal washes for testing by singleplex reverse-